8158 — China Regenerative Medicine International Share News
0.000.00%
Last trade - 00:00- HK$66.94m
- HK$103.36m
- HK$72.06m
Brief: China Regenerative Medicine International says qtrly loss for period HK$68 mln
Brief: China Regenerative Medicine International re-designates Ray Yip to an executive director
Brief: China Regenerative Medicine International Group updates on product expansion
Brief: China Regenerative Medicine International says FY net loss HK$184.5 million
Brief: Valeant agrees to sell Obagi Medical Products business
Brief: China Regenerative Medicine International says during period between 30 May & 6 June, co received notices requesting return of products
Brief: China Regenerative Medicine International proposed subscription for interest in the fund
Brief: China Regenerative Medicine International says Chen Chunguo re-designated as CEO
Brief: China Regenerative Medicine International says Chen Chunguo appointed executive director
Brief: China Regenerative Medicine International updates on potential disposal of shares
Brief: China Regenerative Medicine International Ltd updates on termination negotiation of proposed transaction
Brief: China Regenerative Medicine International updates on disposal of debt receivables
Brief: China regenerative medicine says its unit entered into sale and purchase agreement with transferor, debtor Deng and Hua
Brief: China Regenerative Medicine International says Chen Chunguo will be appointed as president
Brief: China Regenerative Medicine International says Cui Zhanfeng will be appointed as Chairman
Brief: China Regenerative Medicine International enters into a collaboration agreement
Brief: China Regenerative Medicine International appoints Mui chi hung as CFO
Brief: China Regenerative Medicine International enters MOU regarding proposed sale and purchase of cell and stem cell business
Brief: China Regenerative Medicine International updates on disposal of shares by substantial shareholder